Universitätsklinikum Würzburg Kinderklinik und Poliklinik
- Address
- Josef-Schneider-Str. 2, 97080 Würzburg, Germany
High‑Risk Neuroblastoma
Clinical research at the Universitätsklinikum Würzburg Kinderklinik und Poliklinik is evaluating innovative treatment strategies for high‑risk neuroblastoma in children, aiming to improve long‑term event‑free survival through intensified chemotherapy and targeted immune therapy.
- Intensive high‑dose chemotherapy regimens
- Chemoimmunotherapy with dinutuximab beta
- Radiotherapy dose escalation for residual disease
- Assessment of three‑year event‑free survival rates
The study brings together a multinational team of investigators, leveraging the pediatric oncology expertise of the Würzburg site to refine therapeutic approaches for this aggressive cancer.
Stage IV Childhood Renal Tumour
The department is conducting trials on stage IV childhood renal tumour with pulmonary and extra‑pulmonary metastases, comparing two six‑week preoperative chemotherapy schedules to determine which offers the best metastatic rapid response.
- Metastatic rapid response assessment
- Pulmonary and non‑pulmonary metastasis evaluation
- Six‑week preoperative chemotherapy protocols
- Non‑inferiority analysis of treatment strategies
Findings from this research aim to optimize treatment pathways for children facing advanced renal cancer, contributing valuable data from the Würzburg pediatric oncology centre.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1GPOH gGmbH1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Universitätsklinikum Würzburg Kinderklinik und Poliklinik
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase 3 Non-Inferiority Trial of Vincristine, Actinomycin-D, and Doxorubicin Versus Vincristine, Carboplatin, and Etoposide in Stage IV Pediatric Renal Tumors | GPOH gGmbH | Phase III | Recruiting | Dec 2019 | — |
IMP list
lock Showing 1 of 13 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Carboplatin | 2 | Unknown | 2019-12-05 | 2024-11-21 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.